Wells Fargo & Company CYCLACEL PHARMACEUTICALS INC Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Number of Shares
33
Previous 40
17.5%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%